Clinical characteristics of children with juvenile dermatomyositis: The childhood arthritis and rheumatology research alliance registry

Arthritis Care and Research

Volumn 66, Issue 3, 2014, Pages 404-410

  Robinson, Angela Byun ^a   Hoeltzel, Mark F ^b   Wahezi, Dawn M ^c   Becker, Mara L ^b   Kessler, Elizabeth A ^d   Schmeling, Heinrike ^e   Carrasco, Ruy ^f   Huber, Adam M ^g   Feldman, Brian M ^h   Reed, Ann M ⁱ  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^d Children's Hospital of Wisconsin ^*  (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f DELL INC   (United States)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; MUSCLE ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTHRITIS; ARTICLE; CALCINOSIS; CHILD; CHILDHOOD DISEASE; CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE; CHILDHOOD MYOSITIS ASSESSMENT SCALE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY SCORE; DISEASE COURSE; DISEASE DURATION; DRUG EXPOSURE; DYSPHAGIA; DYSPHONIA; ELECTROMYOGRAM; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERSTITIAL LUNG DISEASE; JUVENILE DERMATOMYOSITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; QUALITY OF LIFE; RATING SCALE; SCHOOL CHILD; SELF CARE; TELANGIECTASIA;

ADOLESCENT; CHILD; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; REGISTRIES; RHEUMATOLOGY;

EID: 84896879731     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22142     Document Type: Article

References (23)

1. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al, for the NIAMS Juvenile DM Registry Physician Referral Group. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003; 49: 300-5.
2. Bitnum S, Daeschner CW Jr, Travis LB, Dodge WF, Hopps HC,. Dermatomyositis. J Pediatr 1964; 64: 101-31.
3. Sullivan DB, Cassidy JT, Petty RE, Burt A,. Prognosis in childhood dermatomyositis. J Pediatr 1972; 80: 555-63.
4. Cook CD, Rosen FS, Banker BQ,. Dermatomyositis and focal scleroderma. Pediatr Clin North Am 1963; 10: 979-1016.
5. Huber AM, Giannini EH, Bowyer SL, Kim S, Lang B, Lindsley CB, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken) 2010; 62: 219-25.
6. Bohan A, Peter JB,. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
7. Brown VE, Pilkington CA, Feldman BM, Davidson JE,. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) 2006; 45: 990-3.
8. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 2213-9.
9. Singh G, Athreya BH, Fries JF, Goldsmith DP,. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-9.
10. Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology. Clin Exp Rheumatol 2001; 19 Suppl: S1-9.
11. Landgraf JM, Abetz L, Ware JE,. The CHQ user's manual. 1st ed. Boston: The Health Institute; 1996.
12. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F,. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498-502.
13. Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010; 62: 63-72.
14. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland): clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford) 2006; 45: 1255-60.
15. Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N, et al. Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol 2011; 29: 117-24.
16. Kishi T, Miyamae T, Hara R, Nakajima S, Imagawa T, Mori M, et al. Clinical analysis of 50 children with juvenile dermatomyositis. Mod Rheumatol 2013; 23: 311-7.
17. Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998; 25: 1198-204.
18. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005; 53: 166-72.
19. Tse S, Lubelsky S, Gordon M, Al Mayouf SM, Babyn PS, Laxer RM, et al. The arthritis of inflammatory childhood myositis syndromes. J Rheumatol 2001; 28: 192-7.
20. United States Census Bureau. URL: http://www.census.gov/.
21. Martin N, Krol P, Smith S, Beard L, Pilkington CA, Davidson J, et al, on behalf of the Juvenile Dermatomyositis Research Group (JDRG). Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study. Arthritis Care Res (Hoboken) 2012; 64: 1665-72.
22. Stringer E, Bohnsack J, Bowyer SL, Griffin TA, Huber AM, Lang B, et al. Treatment approaches to juvenile dermatomyositis (JDM) across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J Rheumatol 2010; 37: 1953-61.
23. Boulter EL, Beard L, Ryder C, Pilkington CA, and the UK Juvenile Dermatomyositis Research Group (JDRG). Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis [abstract]. Pediatr Rheumatol Online J 2011; 9 Suppl: O29.